Aquestive Therapeutics, Inc. AQST
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2018-07-25
Aquestive Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 5,454,743 | $14.2M | 4.47% |
| TWO SIGMA INVESTMENTS, LP | 1,139,404 | $4.7M | 0.93% |
| CITADEL ADVISORS LLC | 1,019,503 | $4.2M | 0.84% |
| Point72 Asset Management, L.P. | 283,734 | $1.2M | 0.23% |
| AQR CAPITAL MANAGEMENT LLC | 51,594 | $214,116 | 0.04% |
| MILLENNIUM MANAGEMENT LLC | 25,851 | $107,282 | 0.02% |
| D. E. Shaw & Co., Inc. | 18,149 | $75,318 | 0.01% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.